RT Book, Section
A1 Papaliodis, George N.
A1 Rosenbaum, James T.
A2 Stone, John H.
SR Print(0)
ID 1180198793
T1 Ocular Inflammatory Diseases for Rheumatologists
T2 Current Diagnosis & Treatment: Rheumatology, 4e
YR 2021
FD 2021
PB McGraw Hill
PP New York, NY
SN 9781259644641
LK accessmedicine.mhmedical.com/content.aspx?aid=1180198793
RD 2024/04/24
AB The  distance  from  the  surface  of  the  eye  to  the  optic  nerve  is  only  about  2.5  cm,  but  within  that  short  distance,  an  incredible  diversity  of  tissue  resides  and  almost  any  portion  of  that  tissue  can  become  inflamed.  A  rheumatologist  should  have  a  working  knowledge  of  uveitis,  keratitis,  scleritis,  episcleritis,  conjunctivitis,  optic  neuritis,  anterior  ischemic  optic  neuropathy,  dry  eye,  and  orbital  inflammation  because  rheumatologic  diseases  can  be  associated  with  inflammation  in  each  of  these  areas.  Moreover,  managing  a  patient  with  one  of  these  problems  may  require  systemic  immunosuppression,  a  treatment  strategy  that  is  beyond  the  expertise  of  the  vast  majority  of  ophthalmologists.  Ocular  inflammatory  diseases  are  the  third  leading  cause  of  blindness  worldwide  and  account  for  10%  of  cases  of  blindness  in  the  United  States.  Appropriate  management  can  preserve  sight  in  an  organ  that  is  intolerant  of  inflammation.